KRAIG BIOCRAFT LABORATORIES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.06 million for the 12-month period ending 2025-12-31, per its POS AM filed 2026-05-11.
Financial Statements › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-05-11
- KRAIG BIOCRAFT LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $455.61K, a 13.05% decline from fiscal 2022.
- KRAIG BIOCRAFT LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $524.01K, a 4.38% decline from fiscal 2021.
- KRAIG BIOCRAFT LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $548.00K, a 25.75% increase from fiscal 2020.
- KRAIG BIOCRAFT LABORATORIES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $435.80K, a 28.66% decline from fiscal 2019.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $1.06M POS AM · filed 2026-05-11 |
| 2024-12-31 | $533.17K POS AM · filed 2026-05-11 |
| 2023-12-31 | $455.61K 10-K · filed 2024-04-01 |
| 2022-12-31 | $524.01K 10-K · filed 2024-04-01 |
| 2021-12-31 | $548.00K 10-K · filed 2023-03-29 |
| 2020-12-31 | $435.80K 10-K · filed 2022-03-16 |
| 2019-12-31 | $610.85K 10-K · filed 2021-03-12 |
| 2018-12-31 | $1.41M 10-K · filed 2020-03-27 |
| 2015-12-31 | $495.16K 10-K · filed 2016-03-30 |
| 2014-12-31 | $413.92K 10-K · filed 2016-03-30 |
| 2013-12-31 | $385.85K 10-K · filed 2015-03-31 |
| 2012-12-31 | $220.95K 10-K · filed 2014-04-15 |
| 2011-12-31 | $439.88K 10-K/A · filed 2013-12-24 |